Is a complete CTSO research report available?

No complete published report is available for Cytosorbents Corporation (CTSO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Cytosorbents Corporation (CTSO)

NASDAQ: CTSO · USD

$0.36

-0.00 (-0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CTSO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	22.6M
Revenue (ttm)	37.2M
Net income (ttm)	-11.8M
EPS (ttm)	-$0.19
Shares out	62.8M
Volume	37,859
Beta	1.39
Price target	$2.88	+700.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 37.2M
Net income (ttm): -11.8M
EPS (ttm): -$0.19
Market cap: 22.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CTSO indicators

Market & fundamental data

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001175151
Company name	Cytosorbents Corporation
Country	United States
Country code	US
Cusip	23283X206
Employees	129
Employees Change	-20%
Employees Change Percent	-13.42
Enterprise value	$47.1M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	40.31
Industry PE Fwd	18.65
Isin	US23283X2062
Last refreshed	2026-07-25
Market cap	$22.6M
Market cap category	Nano-Cap
Price	$0.36
Price currency	USD
Rev Per Employee	288,372.09x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	3841
Symbol	CTSO
Website	https://www.cytosorbents.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-52.4%
EV Sales Forward	1.17x
EV/Sales	1.27x
FCF yield	-45.31%
P/B ratio	10.33x
P/S ratio	0.61x
PS Forward	0.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-72.8%
EBITDA Margin	-70.63%
Gross margin	71.01%
Gross Profit	$26.4M
Gross Profit Growth	9.06%
Gross Profit Growth Q	-1.24%
Gross Profit Growth3 Y	10.13%
Gross Profit Growth5 Y	-3.89%
Net Income	$-11.8M
Net Income Growth Years	3%
Pretax Margin	-32.93%
Profit Margin	-31.85%
Profit Per Employee	$-91,845
ROA	-18.33
Roa5y	-23.09
ROCE	-57.32
ROE	-141.6
Roe5y	-83.44
ROIC	-22.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-22.53%
Cagr15y	-16.36%
Cagr1y	-64.73%
Cagr3y	-54.18%
Cagr5y	-45.46%
EPS Growth Years	3
Revenue Growth	5.29x
Revenue Growth Q	1.57x
Revenue Growth Quarters	4x
Revenue Growth Years	2x
Revenue Growth3 Y	1.62x
Revenue Growth5 Y	-2.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.81
Assets	$40.6M
Cash	$4.8M
Current Assets	$17.8M
Current Liabilities	$16.3M
Debt	$29.3M
Debt Equity	$13.34
Equity	$2.2M
Interest Coverage	-4.86
Liabilities	$38.4M
Long Term Assets	$22.8M
Long Term Liabilities	$22.1M
Net Cash	$-24.5M
Net Cash By Market Cap	$-108
Net Debt Equity	$11.15
Tangible Book Value	$-758,000
Tangible Book Value Per Share	$-0.01
WACC	9.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Inventory Turnover	2.88
Net Working Capital	$3.9M
Quick ratio	0.73
Working Capital	$1.5M
Working Capital Turnover	$4.34

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.21%
1Y total return	-64.71%
200-day SMA	0.63
3Y total return	-90.39%
50-day SMA	0.43
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.17%
All Time High	50,000
All Time High Change	-100%
All Time High Date	2006-08-07
All Time Low	0.35
All Time Low Change	2.86%
All Time Low Date	2026-07-17
ATR	0.04
Beta	1.39
Beta1y	2.12
Beta2y	0.75
Ch YTD	-43.68
High	0.38
High52	1.22
High52 Date	2025-08-11
High52ch	-70.49%
Low	0.36
Low52	0.35
Low52 Date	2026-07-17
Low52ch	2.86%
Ma50ch	-16.63%
Price vs 200-day SMA	-42.99%
RSI	40.83
RSI Monthly	35.71
RSI Weekly	30.62
Sharpe ratio	-0.96x
Sortino ratio	-1.29
Total Return	-12.01%
Tr YTD	-43.68
Tr15y	-93.14%
Tr1m	-16.08%
Tr3m	-44.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Hold
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	9,348,880x
Earnings Revenue Estimate Growth	-2.79x
Operating Income	$-13.4M
Operating margin	-36.01
Price target	$2.88
Price Target Change	$700

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	53,939,023%
Float Percent	85.9%
Net Borrowing	2,478,000
Shares Insiders	14.1%
Shares Institutions	26.27%
Shares Out	62,794,748
Shares Qo Q	-0.1%
Shares Yo Y	12.01%
Short Float	3.85%
Short Ratio	6.87
Short Shares	3.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.7M
Average Volume	90,951.15x
Bv Per Share	0.03
CAPEX	$-173,000
Ch10y	-92.21
Ch15y	-93.14
Ch1m	-16.08
Ch1y	-64.71
Ch3m	-44.44
Ch3y	-90.39
Ch5y	-95.17
Ch6m	-47.07
Change	-0.39%
Change From Open	-3.49
Close	0.36
Days Gap	3.21
Depreciation Amortization	1,477,000
Dollar Volume	13,629.2
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-13.9M
EBITDA	$-13.5M
EPS	$-0.19
F Score	4
FCF	$-10.2M
FCF EV Yield	-21.77x
FCF Per Share	$-0.16
Financing CF	2,478,000
Fiscal Year End	December
Founded	1,997
Income Tax	$-401,000
Investing CF	-414,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-13
Last Report Date	2026-03-31
Last Split Date	2014-12-05
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	0.58
Ma150ch	-38.36%
Ma20	0.38
Ma20ch	-5.78%
Net CF	-6,775,000
Next Earnings Date	2026-08-06
Open	0.37
Optionable	Yes
Position In Range	0
Post Close	0.36
Postmarket Change Percent	2
Postmarket Price	$0.37
Ppne	18,279,000
Price Date	2026-07-24
Relative Volume	0.42x
Revenue	37,200,000x
SBC By Revenue	6.7x
Share Based Comp	2,491,000
Tax By Revenue	-1.08x
Tr6m	-47.07%
Us State	New Jersey
Volume	37,859
Z Score	-10.24

Cytosorbents Corporation (CTSO)

Coverage state: Market snapshot only — no published research

Generate the first CTSO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CTSO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CTSO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CTSO

Frequently asked questions